https://peptide.global/story/samsung-biologics-polypeptide-tender-end-resultPeptide Globalen2026-11-03T05:51:00.000ZSamsung Biologics PolyPeptide tender offer ends near 98 percent with settlement waiting on four markets https://peptide.global/story/korea-obesity-drug-survey-gen-zPeptide Globalen2026-11-03T05:23:00.000ZKorea obesity drug survey shows Gen Z leading GLP 1 use https://peptide.global/story/asia-pacific-obesity-drug-pipeline-china-koreaPeptide Globalen2026-11-02T06:16:00.000ZAsia Pacific obesity drug pipeline led by China as Korea gains ground https://peptide.global/story/sun-pharma-oral-semaglutide-cdsco-approvalPeptide Globalen2026-11-02T05:43:00.000ZSun Pharma oral semaglutide wins CDSCO approval with an Assam plant and a Chinese ingredient